Dermatol. praxi. 2019;13(1):14-19 [Interní Med. 2018; 20(4): 189-196]

How to examine and support microcirculation in pactients with diabetic foot

MUDr. Pavlína Piťhová, Ph.D.
Interní klinika 2. LF UK a FN v Motole, Praha

Diabetic foot syndrome is a debilitating diabetic complication. The treatment must be complex, containing offloading of the
affected foot, revascularization procedures in presence of ischemia, antibiotic treatment if infection is present, debridement and
proper wound bed preparation and optimal wound care choice. It seems that the most important role in healing process plays
functional microcirculation. In support of microcirculation we can use non-pharmacological (hyperbaric oxygenotherapy, local
physical treatments) and pharmacological methods as alprostadile or sulodexide.

Keywords: diabetic foot, support of microcirculation, alprostadile, sulodexide, hyperbaric oxygentherapy, NPWT therapy

Published: March 21, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Piťhová P. How to examine and support microcirculation in pactients with diabetic foot. Dermatol. praxi. 2019;13(1):14-19.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Fagrell B, Intaglieta M. Microcirculation: its significance in clinical and molecular medicine. J. Intern. Med., 1997, 241, p. 349-362. Go to original source... Go to PubMed...
    2. Freccero C, Holmlund F, Bornmyr S et al.: Laser Doppler perfusion monitoring of skin blood flow at different depths in finger and arm upon local heating. Microvasc Res. 2003 Nov; 66(3): 183-189. Go to original source... Go to PubMed...
    3. Hamdy O, Abou-Elenin K, LoGerfo FW et al. Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. Diabetes Care. 2001 Feb; 24(2): 344-349. Go to original source... Go to PubMed...
    4. Caballero AE, Arora S, Saouaf R et al. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.Diabetes. 1999 Sep; 48(9): 1856-1862. Go to original source... Go to PubMed...
    5. Matsumoto Y, Ohno H, Noguchi I et al. Disturbance of microcirculation due to unhealthy lifestyle: Cause of type 2 diabetes.Med Hypotheses. 2006; 66(3): 550-553. Go to original source... Go to PubMed...
    6. Gärtner V, Eigentler TK.: Pathogenesis of diabetic macro- and microangiopathy. Clin Nephrol. 2008 Jul; 70(1):1-9. Go to original source... Go to PubMed...
    7. Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation. 2003 Oct 28; 108(17): 2054-2059. Go to original source... Go to PubMed...
    8. Esper RJ, Nordaby RA, Vilari?o JO et al. Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol. 2006 Feb 23; 5: 4. Go to original source... Go to PubMed...
    9. Doronzo G, Viretto M, Russo I et al. Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: influence of insulin resistance and oxidative stress.Atherosclerosis. 2011 May; 216(1): 44-53. Go to original source... Go to PubMed...
    10. Szabó C, Zanchi A, Komjáti K et al. Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation. 2002 Nov 19; 106(21): 2680-2686. Go to original source... Go to PubMed...
    11. Iwase M, Imoto H, Murata A et al.: Altered postural regulation of foot skin oxygenation and blood flow in patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2007 Jul; 115(7): 444-447. Go to original source... Go to PubMed...
    12. Jörneskog G, Brismar K, Fagrell B. Skin capillary circulation severely impaired in toes of patients with IDDM, with and without late diabetic complications.Diabetologia. 1995 Apr; 38(4): 474-480. Go to original source... Go to PubMed...
    13. Bollinger, A., Fagrell, B. (Ed) Clinical Capillaroscopy: A guide to Its Use in Clinical Research and Practice.Toronto :Hogrefe & Huber Publishers, 1990.
    14. De Baker, D., Dubois, M. J. Assessment of the microcirculatory flow in patients in the intensive care unit. Curr. Opin. Crit. Care, 2001, 7, p. 200-203. Go to original source...
    15. Cerny V., Turek Z., Parizkova R. Orthogonal polarization spectral imaging. Physiol. Res., 2007, 56, 2, p. 141-147. Go to original source...
    16. Tomešová J, Gruberová J, Brož P. et al. Metody vyšetřování mikrocirkulace kůže. Vnitř Lék 2013; 59(10): 895-902. Go to PubMed...
    17. Vollmer M, Möllmann KP. Infrared thermal imaging: fundamentals, research and applications. Weinheim: Wiley-VCH, c2010. ISBN 35-274-0717-0. Go to original source...
    18. Lowry D, Saeed M, Narendran. et al. The Difference Between the Healing and the Nonhealing Diabetic Foot Ulcer: A Review of the Role of the Microcirculation. J Diabetes Sci Technol. 2017 Sep; 11 (5): 914-923. Go to original source... Go to PubMed...
    19. Robertson L, Andras A. Prostanoids for intermittent claudication. Cochrane Database Syst Rev. 2013; 4: CD000986. doi: 10.1002/14651858.CD000986.pub3 Go to original source... Go to PubMed...
    20. Broekhuizen LN, Lemkes BA, Mooij HL et al. Effect of sulodexide on endothelial glycocalyx and vascular permeability in patiens with type 2 diabetes mellitus. Diabetologia 2010; 53: 2646-2655. doi: 10.1007/s00125-010-1910-x Go to original source... Go to PubMed...
    21. Coccheri S. Biological and clinical effects of sulodexide in arterial disorders and diseases. Int Angiol 2014; 33: 263-274. Go to PubMed...
    22. Piaggessi A., Abbruzzese L, Mattaliano C, et al. Sulodexide as Adjunctive Therapy in Diabetic Foot Patients With Critical Limb Ischemia Treated With Percutaneous Transluminal Angioplasty. Int J Low Extrem Wounds. 2014 May 25; 13(2): 103-109. Go to original source... Go to PubMed...
    23. Coccheri S, Scondotto G, Agnelli G et al. Venous arm of the SUAVIS (Sulodexide Arterial Venous Italian Study) Group. Randomised, double-blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers. Thromb Haemost 2002; 87: 947-952. Go to original source... Go to PubMed...
    24. Andreozzi GM, Bignamini AA, Davi G et al. Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Circulation. 2015 Nov 17; 132(20): 1891-1897. Go to original source... Go to PubMed...
    25. Rathsman B, Jensen-Urstad K, Nyström T. Intensified insulin treatment is associated with improvement in skin microcirculation and ischaemic foot ulcer in patients with type 1 diabetes mellitus: a long-term follow-up study. Diabetologia (2014) 57: 1703-1710. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.